![]() |
인쇄하기
취소
|
While prices of the globally-expanded new drugs have been outlined, the industry complained this year’s policy is only tin god.
It judges the policy contains tight conditions yet low benefits; in the worst cases, some multinational pharmaceutical companies have argued their own new drugs have been discriminated in value.
According to the Ministry of Health and Welfare(MOHW) and the pharmaceut...